Man Group PLC Aquestive Therapeutics, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 12,653 shares of AQST stock, worth $60,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,653
Previous 222,086
94.3%
Holding current value
$60,354
Previous $946,000
96.62%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AQST
# of Institutions
115Shares Held
46MCall Options Held
271KPut Options Held
212K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$46.8 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$26.5 Million1.58% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$20.3 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$13.2 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $254M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...